Mizuho Medy Co.,Ltd. (4595.T) Comparison with companies in other sectors?

Mizuho Medy Co.,Ltd. has a share price of 19.05M. You can analyze Mizuho Medy Co.,Ltd. (4595.T) competitors across different market sectors through stock heatmaps.

What are 4595.T's NET and operating margins?

Mizuho Medy Co.,Ltd. (4595.T) operating margin is around 0.42, and net profit margin is approximately 0.32 as of the latest reports.

In what way does 4595.T's earnings per share (EPS) trend reflect its financial momentum?

Mizuho Medy Co.,Ltd. (4595.T) EPS is 198.08 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Mizuho Medy Co.,Ltd. is 7.20, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Mizuho Medy Co.,Ltd.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Mizuho Medy Co.,Ltd. like P/E which is 7.59, P/B which is 1.60, and PEG which is -0.27. Compare them with sector averages to evaluate if the stock is priced fairly.

Mizuho Medy Co.,Ltd.

4595.T•JPX

Healthcare

Drug Manufacturers - Specialty & Generic

¥1426.00

¥3.00(0.21%)

Mizuho Medy Co.,Ltd. (4595.T) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$198.08

P/E Ratio

7.20

ROE

0.22%

Net Margin

0.32%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$27.16B

Shares OutstandingTotal number of shares issued

$19.05M

Book Value/ShareNet worth per share

$891.93

Revenue/ShareAnnual revenue per share

$595.11

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$198.08

Net MarginNet income as percentage of revenue

31.58%

Operating MarginOperating income as percentage of revenue

42.25%

ROEReturn on shareholders' equity

21.60%

ROAReturn on total assets

17.77%

ROCEReturn on capital employed

26.63%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

$578.41

FCF YieldFree cash flow as percentage of market cap

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$100.00

Dividend YieldAnnual dividend as percentage of stock price

7.01%

Financial Ratios Analysis data is not available for 4595.TFinancial Ratios Analysis details for 4595.T are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for 4595.TSector Benchmarking details for 4595.T are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Mizuho Medy Co.,Ltd. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Mizuho Medy Co.,Ltd.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Mizuho Medy Co.,Ltd.'s unique business strengths and challenges.

Key Financial Metrics for Mizuho Medy Co.,Ltd.

For Mizuho Medy Co.,Ltd., essential financial indicators include EPS 198.08, PE 7.20, and ROE 0.22. These key ratios reveal insights into Mizuho Medy Co.,Ltd.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Mizuho Medy Co.,Ltd. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Mizuho Medy Co.,Ltd.

Metrics like Net Margin 31.58% and ROA 17.77% shed light on how well Mizuho Medy Co.,Ltd. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Mizuho Medy Co.,Ltd. can sustain its operations and continue growing in the future.

Valuation and Market Position of Mizuho Medy Co.,Ltd.

Using ratios such as P/B Ratio 1.60 and PEG Ratio -0.27, investors can assess whether Mizuho Medy Co.,Ltd. is appropriately valued based on its financials and growth potential. These figures, combined with Mizuho Medy Co.,Ltd.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Mizuho Medy Co.,Ltd.

Financial health indicators, such as Debt/Equity Ratio - and Cash Flow -, provide a snapshot of Mizuho Medy Co.,Ltd.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Mizuho Medy Co.,Ltd., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Mizuho Medy Co.,Ltd.

Investing in Mizuho Medy Co.,Ltd. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Mizuho Medy Co.,Ltd. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;